Feiba 1000 U/20 mL (50 U/mL) Powder for Solution for Infusion (IV)
Pajjiż: Filippini
Lingwa: Ingliż
Sors: FDA (Food And Drug Administration)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Factor VIII Inhibitor Bypassing Activity
Disponibbli minn:
N/A; Importer: Takeda Healthcare Philippines Inc.; Distributor: Takeda Healthcare Philippines Inc.
INN (Isem Internazzjonali):
Factor VIII Inhibitor Bypassing Activity
Dożaġġ:
1000 U/20 mL (50 U/mL)
Għamla farmaċewtika:
Powder for Solution for Infusion (IV)
Unitajiet fil-pakkett:
500, 1000, and 2500 units (U) per vial supplied with a diluent in a vial containing steril water for injection
Manifatturat minn:
Baxter AG, Austria
Data ta 'l-awtorizzazzjoni:
2023-06-19
